Goldman Sachs’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.4M Buy
3,406,456
+55,979
+2% +$242K ﹤0.01% 2663
2026
Q1
$13M Buy
3,350,477
+1,176,544
+54% +$4.83M ﹤0.01% 2839
2025
Q4
$9.09M Buy
2,173,933
+1,440,446
+196% +$5.57M ﹤0.01% 3183
2025
Q3
$2.41M Buy
733,487
+228,139
+45% +$644K ﹤0.01% 4321
2025
Q2
$718K Buy
505,348
+171,836
+52% +$244K ﹤0.01% 4931
2025
Q1
$497K Sell
333,512
-174,020
-34% -$274K ﹤0.01% 5190
2024
Q4
$568K Buy
507,532
+62,219
+14% +$53.1K ﹤0.01% 5174
2024
Q3
$422K Buy
445,313
+110,388
+33% +$139K ﹤0.01% 5146
2024
Q2
$529K Buy
334,925
+50,489
+18% +$73.3K ﹤0.01% 4800
2024
Q1
$412K Sell
284,436
-634
-0.2% -$910 ﹤0.01% 4838
2023
Q4
$382K Sell
285,070
-99,784
-26% -$117K ﹤0.01% 4884
2023
Q3
$546K Buy
384,854
+72,935
+23% +$103K ﹤0.01% 4615
2023
Q2
$359K Sell
311,919
-7,404
-2% -$8.74K ﹤0.01% 4917
2023
Q1
$338K Buy
319,323
+5,499
+2% +$7.93K ﹤0.01% 5045
2022
Q4
$477K Buy
313,824
+16,321
+5% +$28.1K ﹤0.01% 4892
2022
Q3
$630K Sell
297,503
-40,533
-12% -$85.5K ﹤0.01% 4822
2022
Q2
$453K Sell
338,036
-511,428
-60% -$759K ﹤0.01% 5149
2022
Q1
$1.79M Buy
849,464
+439,368
+107% +$1.07M ﹤0.01% 4345
2021
Q4
$1.52M Buy
410,096
+49,811
+14% +$214K ﹤0.01% 4480
2021
Q3
$1.8M Buy
360,285
+141,797
+65% +$816K ﹤0.01% 4295
2021
Q2
$1.42M Buy
218,488
+17,481
+9% +$122K ﹤0.01% 4490
2021
Q1
$1.39M Sell
201,007
-21,127
-10% -$179K ﹤0.01% 4346
2020
Q4
$2.27M Sell
222,134
-125,586
-36% -$814K ﹤0.01% 3637
2020
Q3
$1.22M Buy
347,720
+71,576
+26% +$340K ﹤0.01% 3941
2020
Q2
$1.38M Sell
276,144
-55,833
-17% -$190K ﹤0.01% 3737
2020
Q1
$1.13M Buy
331,977
+19,798
+6% +$85.4K ﹤0.01% 3670
2019
Q4
$1.71M Sell
312,179
-30,812
-9% -$173K ﹤0.01% 3757
2019
Q3
$1.96M Sell
342,991
-53,267
-13% -$362K ﹤0.01% 3545
2019
Q2
$3.04M Buy
396,258
+45,052
+13% +$243K ﹤0.01% 3231
2019
Q1
$1.85M Sell
351,206
-60,860
-15% -$422K ﹤0.01% 3692
2018
Q4
$2.69M Buy
412,066
+50,848
+14% +$570K ﹤0.01% 3341
2018
Q3
$6.22M Buy
361,218
+85,471
+31% +$1.27M ﹤0.01% 2813
2018
Q2
$3.84M Buy
275,747
+29,245
+12% +$494K ﹤0.01% 3145
2018
Q1
$3.78M Buy
246,502
+6,761
+3% +$96.7K ﹤0.01% 3116
2017
Q4
$2.76M Buy
239,741
+71,538
+43% +$1.07M ﹤0.01% 3521
2017
Q3
$3.2M Buy
168,203
+15,627
+10% +$322K ﹤0.01% 3558
2017
Q2
$3.67M Buy
152,576
+8,148
+6% +$179K ﹤0.01% 3315
2017
Q1
$2.86M Buy
144,428
+53,367
+59% +$1.19M ﹤0.01% 3412
2016
Q4
$2.19M Sell
91,061
-336,145
-79% -$9.36M ﹤0.01% 3766
2016
Q3
$11.9M Sell
427,206
-62,674
-13% -$1.66M ﹤0.01% 2317
2016
Q2
$11.9M Buy
489,880
+272,709
+126% +$7.74M ﹤0.01% 2181
2016
Q1
$7.29M Sell
217,171
-39,557
-15% -$1.25M ﹤0.01% 2457
2015
Q4
$7.67M Buy
256,728
+184,284
+254% +$6.21M ﹤0.01% 2467
2015
Q3
$2.28M Sell
72,444
-7,276
-9% -$355K ﹤0.01% 3654
2015
Q2
$3.86M Buy
79,720
+33,415
+72% +$1.41M ﹤0.01% 3186
2015
Q1
$2.01M Sell
46,305
-53,784
-54% -$1.93M ﹤0.01% 3775
2014
Q4
$2.63M Buy
100,089
+87,937
+724% +$1.93M ﹤0.01% 3566
2014
Q3
$216K Sell
12,152
-6,340
-34% -$129K ﹤0.01% 6087
2014
Q2
$444K Buy
+18,492
New +$375K ﹤0.01% 5436
2013
Q4
Sell
-8,901
Closed -$202K 6769
2013
Q3
$202K Buy
+8,901
New +$205K ﹤0.01% 5864

Other funds holding PGEN

Goldman Sachs's PGEN Position: Q2 2026 in Review

Goldman Sachs increased its Precigen (PGEN) stake by 1.7% in Q2 2026, buying an estimated $242K and bringing the position to 3,406,456 shares worth $19.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2663.

Goldman Sachs first reported a position in PGEN in Q3 2013 and has held it in 50 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Goldman Sachs held 3,406,456 shares of Precigen worth $19.4M as of Q2 2026.
  • Goldman Sachs bought 55,979 Precigen shares in Q2 2026, an estimated $242K.
  • Precigen made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2663 holding.
  • Goldman Sachs first reported a position in Precigen in Q3 2013 and has held it in 50 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.